Skip to main content

Table 3 Participants' baseline features

From: Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

Studies Age (years) Males (%) HTN (%) DS (%) CS (%)
ITDM/NITDM ITDM/NITDM ITDM/NITDM ITDM/NITDM ITDM/NITDM
Banning et al. [6] 65.4/65.4 71.0/71.0 69.9/69.9 81.5/81.5 15.8/15.8
Jain et al. [7] 66.6/64.9 62.2/71.8 82.1/77.5 67.9/67.7 13.9/18.0
Jiang et al. [8] 65.1/66.8 72.1/74.2 75.0/76.1 79.4/78.0 25.0/22.8
Kereiakes et al. [9] 63.3/63.3 63.3/63.3 87.0/87.0 82.5/82.5 18.3/18.3
Nakamura et al. [10] 66.2/67.2 66.2/75.4 68.1/72.0 58.0/60.4 12.1/19.5
Silber et al. [11] 64.6/65.5 56.4/70.4 91.6/86.0 86.8/86.0 17.2/18.6
Simek et al. [12] 65.1/65.1 69.2/69.2 70.6/70.6 65.5/65.5 32.1/32.1
  1. ITDM insulin-treated diabetes mellitus, NITDM non-insulin-treated diabetes mellitus, HTN hypertension, DS dyslipidemia, CS current smoker